Sherrie L Aspinall1,2,3, Sydney P Springer1,2,3, Xinhua Zhao1,2, Francesca E Cunningham1, Carolyn T Thorpe2,3, Todd P Semla1,4,5, Ronald I Shorr6,7, Joseph T Hanlon2,3,8,9,10. 1. Veterans Affairs Pharmacy Benefits Management Services, Hines, Illinois. 2. Center for Health Equity Research and Promotion Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania. 3. Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania. 4. Department of Medicine, Northwestern University, Chicago, Illinois. 5. Department of Psychiatry and Behavioral Sciences Feinberg School of Medicine, Northwestern University, Chicago, Illinois. 6. Geriatric Research, Education and Clinical Center, Malcolm Randall Veterans Affairs Medical Center, Gainesville, Florida. 7. Department of Epidemiology, Colleges of Public Health and Health Professions & Medicine, University of Florida, Gainesville, Florida. 8. Division of Geriatrics, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. 9. Department of Epidemiology School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania. 10. Geriatric Research, Education and Clinical Center, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania.
Abstract
OBJECTIVES: To examine the association between central nervous system (CNS) medication dosage burden and risk of serious falls, including hip fractures, in individuals with a history of a recent fall. DESIGN: Nested case-control study. SETTING: Veterans Health Administration (VHA) Community Living Centers (CLCs). PARTICIPANTS: CLC residents aged 65 and older with a history of a fall or hip fracture in the year before a CLC admission between July 1, 2005, and June 30, 2009. Each case (n = 316) was matched to four controls (n = 1264) on age, sex, and length of stay. MEASUREMENTS: Outcomes were serious falls identified using International Classification of Diseases, Ninth Revision (ACD-9) or Current Procedural Terminology (CPT) E codes, diagnosis codes, or procedure codes associated with a VHA emergency department visit or hospitalization during the CLC stay. Bar code medication administration data were used to calculate CNS standardized daily doses (SDDs) for opioid and benzodiazepine receptor agonists, some antidepressants, antiepileptics, and antipsychotics received in the 6 days before the outcome date by dividing residents' actual CNS daily doses by the minimum effective geriatric daily doses and adding the results. Multivariable conditional logistic regression models were used to evaluate the association between total CNS medication dosage burden, categorized as 0, 1 to 2, and 3 or more SDDs, and the outcome of recurrent serious falls. RESULTS: More cases (44.3%) than controls (35.8%) received 3.0 or more CNS SDDs (p = .02). Risk of serious falls was greater in residents with 3.0 or more SDDs than in those with 0 (adjusted odds ratio (aOR)=1.49, 95% confidence interval (CI)=1.03-2.14). Those with 1.0 to 2.9 SDDs had a risk similar to that of those with 0 SDDs (aOR=1.03, 95%CI=0.72-1.48). CONCLUSION: Nursing home residents with a history of a fall or hip fracture receiving 3.0 or more CNS SDDs were more likely to have a recurrent serious fall than those taking no CNS medications. Interventions targeting this vulnerable population may help reduce serious falls. J Am Geriatr Soc 67:74-80, 2019. Published 2018. This article is a U.S. Government work and is in the public domain in the USA.
OBJECTIVES: To examine the association between central nervous system (CNS) medication dosage burden and risk of serious falls, including hip fractures, in individuals with a history of a recent fall. DESIGN: Nested case-control study. SETTING: Veterans Health Administration (VHA) Community Living Centers (CLCs). PARTICIPANTS: CLC residents aged 65 and older with a history of a fall or hip fracture in the year before a CLC admission between July 1, 2005, and June 30, 2009. Each case (n = 316) was matched to four controls (n = 1264) on age, sex, and length of stay. MEASUREMENTS: Outcomes were serious falls identified using International Classification of Diseases, Ninth Revision (ACD-9) or Current Procedural Terminology (CPT) E codes, diagnosis codes, or procedure codes associated with a VHA emergency department visit or hospitalization during the CLC stay. Bar code medication administration data were used to calculate CNS standardized daily doses (SDDs) for opioid and benzodiazepine receptor agonists, some antidepressants, antiepileptics, and antipsychotics received in the 6 days before the outcome date by dividing residents' actual CNS daily doses by the minimum effective geriatric daily doses and adding the results. Multivariable conditional logistic regression models were used to evaluate the association between total CNS medication dosage burden, categorized as 0, 1 to 2, and 3 or more SDDs, and the outcome of recurrent serious falls. RESULTS: More cases (44.3%) than controls (35.8%) received 3.0 or more CNS SDDs (p = .02). Risk of serious falls was greater in residents with 3.0 or more SDDs than in those with 0 (adjusted odds ratio (aOR)=1.49, 95% confidence interval (CI)=1.03-2.14). Those with 1.0 to 2.9 SDDs had a risk similar to that of those with 0 SDDs (aOR=1.03, 95%CI=0.72-1.48). CONCLUSION: Nursing home residents with a history of a fall or hip fracture receiving 3.0 or more CNS SDDs were more likely to have a recurrent serious fall than those taking no CNS medications. Interventions targeting this vulnerable population may help reduce serious falls. J Am Geriatr Soc 67:74-80, 2019. Published 2018. This article is a U.S. Government work and is in the public domain in the USA.
Entities:
Keywords:
central nervous system agents; falls; older
Authors: Nicholas M Wilson; Sarah N Hilmer; Lyn M March; Ian D Cameron; Stephen R Lord; Markus J Seibel; Rebecca S Mason; Jian Shen Chen; Robert G Cumming; Philip N Sambrook Journal: J Am Geriatr Soc Date: 2011-05-03 Impact factor: 5.562
Authors: Denis O'Mahony; David O'Sullivan; Stephen Byrne; Marie Noelle O'Connor; Cristin Ryan; Paul Gallagher Journal: Age Ageing Date: 2014-10-16 Impact factor: 10.668
Authors: Sydney P Springer; Maria K Mor; Florentina Sileanu; Xinhua Zhao; Sherrie L Aspinall; Mary Ersek; Joshua D Niznik; Joseph T Hanlon; Jacob Hunnicutt; Walid F Gellad; Loren J Schleiden; Joshua M Thorpe; Carolyn T Thorpe Journal: J Am Geriatr Soc Date: 2020-02-13 Impact factor: 5.562
Authors: Lena K Makaroun; Carolyn T Thorpe; Maria K Mor; Hongwei Zhang; Elijah Lovelace; Tony Rosen; Melissa E Dichter; Ann-Marie Rosland Journal: J Gerontol A Biol Sci Med Sci Date: 2022-08-12 Impact factor: 6.591
Authors: Shelly L Gray; Zachary A Marcum; Sascha Dublin; Rod Walker; Negar Golchin; Dori E Rosenberg; Erin J Bowles; Paul Crane; Eric B Larson Journal: J Gerontol A Biol Sci Med Sci Date: 2020-04-17 Impact factor: 6.053
Authors: Amy L Shaver; Collin M Clark; Mary Hejna; Steven Feuerstein; Robert G Wahler; David M Jacobs Journal: Pharmacoepidemiol Drug Saf Date: 2021-02-16 Impact factor: 2.732
Authors: Rebecca T Emeny; Chiang-Hua Chang; Jonathan Skinner; A James O'Malley; Jeremy Smith; Gouri Chakraborti; Clifford J Rosen; Nancy E Morden Journal: JAMA Netw Open Date: 2019-11-01
Authors: Yu-Seon Jung; David Suh; Hang-Seok Choi; Hee-Deok Park; Sun-Young Jung; Dong-Churl Suh Journal: Int J Environ Res Public Health Date: 2022-02-17 Impact factor: 3.390
Authors: Catarina Caçador; Edite Teixeira-Lemos; Jorge Oliveira; João Pinheiro; Luís Teixeira-Lemos; Fernando Ramos Journal: Int J Environ Res Public Health Date: 2022-02-24 Impact factor: 3.390